{'fraction_non_alphanumeric': 0.014677103718199608, 'fraction_numerical': 0.008806262230919765, 'mean_word_length': 5.125748502994012, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1–2 study

ticular value to each blood culture and preventing the consistent analysis of trends. In addition, the very low rate of new isolates and the presence of predictive variables among data collected as part of routine haematological care would not seem to support the adoption of an additional routine test for the purpose of triaging patients for repeat blood cultures. The lack of an allogeneic haematopoetic stem cell transplantation programme at our institution prevented us from examining this particularly high-risk population. In conclusion, follow-up blood cultures in patients with suspected neutropenic sepsis have a low yield for new organisms, particularly for patients with an ANC ≥0 1 9 10/l or diagnoses other than AML. Clinicians should feel comfortable not performing repeat blood cultures unless there is a significant change in a patient’s condition or a specific suspicion of new-onset bacteraemia.